Methotrexate Shortage to End in February, Bedford Says

A methotrexate shortage caused by insufficient manufacturing capacity at Bedford Laboratories should be over by mid-February, the company says. The company released lots of 100- and 200-mg injectable methotrexate in December and will release additional strengths in January, Bedford spokesman Jason Kurtz said.
Drug GMP Report